Clinical Trials Browser

Phase 2 × OTHER × Fanconi Anemia, Complementation Group D1 × Clear all

NCT03344965 2026-01-05

Olaparib In Metastatic Breast Cancer

Phase 2 Active not recruiting

BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT05485766 2025-03-20

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Phase 2 Recruiting

BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01772979 2013-01-21

MITO15

Phase 2 Unknown

Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms